Cytokines Proteomic Study in Post-Stroke Depression: A Preliminary Study

Abstract

Abstract:

Objective To investigate the association between post-stroke depression (PSD) and the level of cytokines in plasma. Methods Plasma spot signal intensity (SIs) of 120 cytokines were measured by Human Cytokine Antibody Array G-Series 1000 in 12 patients with PSD and 12 non-PSD controls who admitted to the hospital within the first 3 days after stroke onset. The diagnoses of PSD were made in accordance with DSM-IV criteria. The 17-item Hamilton Depression Rating Scale (HAMD) and Hamilton Anxiety Scale (HAMA) were used to screen for depressive and anxiety symptoms on days 14 after admission. Results Plasma SIs of 4 cytokines (insulin-like growth factor 1 receptor [IGF-I SR], macrophage inflammatory protein-3 beta [MIP-3 beta], placental growth factor [PIGF], vascular endothelial growth factor [VEGF]) were significantly lower in PSD patients than in non-PSD patients, although these findings were not significant after the false discovery rate (FDR) correction for multiple testing to be applied. No cytokine was independently associated with incidence of PSD at the acute stage of stroke. Plasma SIs of IGF-I SR showed a negative correlation with the Barthel index (r =- 0.641, P =0.025) 1 day after admission and showed positive correlations with the HAMD (r =0.478, P =0.005) and HAMA scores (r =0.674, P =0.016) 14 days after admission. Conclusion Plasma levels of cytokines after ischemic stroke can't serve as a biological marker to predict the incidence of PSD. Dysfunction of synaptic plasticity and neurogenesis may play a causative role in PSD.

Key words: Ischemic stroke; Post-stroke depression; Cytokine; Proteomics

摘要：

目的初步探讨急性缺血性卒中患者血浆120种细胞因子蛋白水平与卒中后抑郁（post-stroke depression，PSD）发生的关系。方法入组PSD及非PSD患者各12例，均为卒中发生后3 d内入院的急性缺血性卒中患者，随访至卒中后 2周，对患者进行神经功能，认知功能及抑郁、焦虑严重程度评估。患者入院后1 d［卒中后（1.5±0.9） d］清晨6∶30留取空腹时静脉血浆标本，利用人类细胞因子蛋白表达微阵列芯片进行120种细胞因子蛋白组学检测。结果与非PSD组相比，PSD组4个细胞因子血浆中点信号强度（spot signal intensity，SIs）显示降低，差异有显著性，分别为胰岛素样生长因子1受体（insulin-like growth factor 1 receptor, IGF-I S R）（P =0.021），巨噬细胞炎症蛋白-3β（macrophage inflammatory protein-3 beta，MIP-3 beta）（P =0.033），胎盘生长因子（placental growth factor，PIGF）（P =0.021），血管内皮生长因子（vascular endothelial growth factor，VEGF）（P =0.015），但均未通过错误发现率多重校正，多因素Logi sti c回归分析无阳性发现。血浆胰岛素样生长因子1受体蛋白SIs与患者入院时Barthel指数呈负相关（r =－0.641， P =0.025），与2周后PSD患者汉密尔顿抑郁量表评分（r =0.478，P =0.005）及汉密尔顿焦虑量表评分（r =0.674，P =0.016）呈正相关。结论本研究的数据尚未发现能独立预测卒中急性期PSD风险的血浆细胞因子，但3种生长因子水平的异常提示PSD可能存在突触可塑及神经再生障碍。

关键词: 缺血性卒中; 卒中后抑郁; 细胞因子; 蛋白组学

GENG Lei-Yu, TANG Hao, LI Wen-Ping, QIAN Fang-Yuan, QIAN Jun-Feng, LI Ling-Jiang, ZHANG Zhi-Jun. Cytokines Proteomic Study in Post-Stroke Depression: A Preliminary Study[J]. Chinese Journal of Stroke, 2014, 9(01): 13-.

耿磊钰，唐浩，李文平，钱方媛，钱俊峰，李凌江，张志珺. 卒中后抑郁细胞因子蛋白组学初探[J]. 中国卒中杂志, 2014, 9(01): 13-.

References

Hackett ML, Yapa C, Parag V, et al. Frequency of depression after stroke:a systematic review of observational studies[J]. Stroke, 2005, 36:1330-1340.

Loubinoux I, Kronenberg G, Endres M, et al. Poststroke depression:mechanisms, translation and therapy[J]. J Cell Mol Med, 2012, 16:1961-1969.

Spalletta G, Bossu P, Ciaramella A, et al. The etiology of post-stroke depression:a review of the literature and a new hypothesis involving inflammatory cytokines[J].Mol Psychiatry, 2006, 11:984-991.

Ya ng L, Zh a ng Z, Su n D, e t a l . The s e r um interleukin-18 is a potential marker for development of post-stroke depression[J]. Neurol Res, 2010, 32:340-346.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition[R].Washington DC:American Psychiatric Association,1994.

陈清棠. 各类脑血管疾病诊断要点[J]. 中华神经科杂志, 1996, 29:379-381.

Sims JR, Gharai LR, Schaefer PW, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes[J]. Neurology, 2009, 72:2104-2110.

中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管杂志, 2011, 39:579-615.

卫生部疾病控制司, 中华医学会糖尿病学分会. 中国糖尿病防治指南[J]. 中国慢性病预防与控制, 2004,12:283-285.

Wor ld He a l t h Orga n i z a t ion . Gu idel i ne s for controlling and monitoring the tobacco epidemic[R].Geneva:Tobacco or Health Programme, WHO, 1997.

Ca s a z z a K, Ha n k s LJ, Alva r e z JA. Rol e of various cytokines and growth factors in pubertal development[J]. Med Sport Sci, 2010, 55:14-31.

Martins-de-Souza D, Harris LW, Guest PC, et al. The role of proteomics in depression research[J]. Eur Arch Psychiatry Clin Neurosci, 2010, 260:499-506.

Filiou MD, Turck CW. Psychiatric disorder biomarker discovery using quantitative proteomics[J]. Methods Mol Biol, 2012, 829:531-539.

Clauss M. Molecular biology of the VEGF and the VEGF receptor family[J]. Semin Thromb Hemost, 2000,26:561-569.

Clark-Raymond A, Halaris A. VEGF and depression:A comprehensive assessment of clinical data[J]. J Psychiatr Res, 2013, 47:1080-1087.

Fou r n ie r NM, Duma n RS. Rol e of va s c u l a r endothelial growth factor in adult hippocampal neurogenesis:implications for the pathophysiology and treatment of depression[J]. Behav Brain Res, 2012,227:440-449.

Nowacka MM, Obuchowicz E. Vascular endothelial growth factor (VEGF) and its role in the central nervous system:a new element in the neurotrophic hypothesis of antidepressant drug action[J]. Neuropeptides, 2012,46:1-10.

Isung J, Mobarrez F, Nordstrom P, et al. Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide[J]. World J Biol Psychiatry,2012, 13:468-473.

Isung J, Aeinehband S, Mobar rez F, et al. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters[J]. Transl Psychiatry, 2012, 2:e196.

Sun R, Li N, Li T. VEGF regulates antidepressant effects of lamotrigine[J]. Eur Neuropsychopharmacol,2012, 22:424-430.

Anderson MF, Aberg MA, Nilsson M, et al. Insulinlike growth factor-I and neurogenesis in the adult mammalian brain[J]. Brain Res Dev Brain Res, 2002,134:115-122.

Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain[J]. ScientificWorld Journal, 2006,6:53-80.

Gunnell D, Lewis S, Wilkinson J, et al. IGF1, growth pathway polymorphisms and schizophrenia:a pooling study[J]. Am J Med Genet B Neuropsychiatr Genet,2007, 144B:117-120.

李则挚, 禹顺英, 洪武, 等. 外周血白细胞脑源性神经营养因子基因表达与亚综合征抑郁的关系[J]. 中华精神科杂志, 2011, 44:3-6.

易正辉, 李则挚, 张晨, 等. 亚综合征抑郁外周血胰岛素样生长因子1受体基因表达研究[J]. 中国神经精神疾病杂志, 2012, 38:732, 737, 746.

Paslakis G, Blum WF, Deuschle M. Intranasal insulinlike growth factor I (IGF-I) as a plausible future treatment of depression[J]. Med Hypotheses, 2012,79:222-225.

[1]	CAO Liming, REN Lijie. Progress and Prospects of Diagnosis and Treatment Techniques for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 983-989.
[2]	FU Pengcheng, CAO Liming, ZHU Jiaqian, ZHAO Guiyu, XU Gelin. Research Progress of Reperfusion Therapy for Large Artery Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1004-1011.
[3]	ZHANG Liping, CAO Liming, XIAO Nan, LIAO Yuqi, CHI Feng, YU Yanni, REN Lijie. Research Progress and Challenges of Nanomaterials in the Diagnosis and Treatment of Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1012-1017.
[4]	WANG Xiaorui, LUO Song, ZOU Liangyu, QU Hongdang, CUI Xue, ZHAO Yujie. Value of Eosinophil-to-Monocyte Ratio in Predicting the Prognosis of Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(9): 1025-1033.
[5]	WANG Shuo, YU Ping, ZHANG Ning, WANG Chunxue. Bibliometric Analysis of References on the Correlation between Ischemic Stroke and Sleep from 2013 to 2023 [J]. Chinese Journal of Stroke, 2024, 19(9): 1040-1047.
[6]	ZHOU Hongyu, LI Zixiao, WANG Yongjun. Research Progress on Radiomics-Based Brain Age Prediction and Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1066-1076.
[7]	ABULANIYAZI Anaguli, WU Xiaoxin, LI Jiaoxing, LI Zhuhao, SHENG Wenli. Research Progress on Factors Related to the Susceptibility Vessel Sign and its Clinical Application in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1077-1085.
[8]	WU Chunyan, YIN Yashi, WANG Guangzhi, YUE Kuitao. Evaluation and Application of Medical Imaging for Acute Ischemic Stroke at Different Time Windows: A Review [J]. Chinese Journal of Stroke, 2024, 19(9): 1094-1101.
[9]	ZHANG Mengruo, XU Shouchen, SUI Cuicui, LI Yukui, WANG Xueli. The Effects of Lower Limb Rehabilitation Robot Combined with Scalp Acupuncture on the Walking Efficiency and Coordination Function in Elderly Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(8): 902-908.
[10]	WU Yuqian, ZHANG Yumei, ZANG Dawei, FAN Xiaowei, WANG Anxin, ZHANG Xiaoli, MENG Xia. Study on the Reliability, Validity, and Sensitivity of Action Research Arm Test Scale in Evaluating the Function of Hemiplegic Upper Limb and Hand in Subacute Stage Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2024, 19(8): 915-923.
[11]	MO Qiuhong, DING Xiaobo, LI Jing, ZHANG Yanbo, LI Weirong. Research on Prediction of Recurrence of Minor Ischemic Stroke Based on Interpretable Machine Learning Models [J]. Chinese Journal of Stroke, 2024, 19(8): 924-930.
[12]	LU Dan, CHEN Weiqi, WANG Yaping, DUAN Wanying, GUO Lei, WANG Ling, LIU Liping, XU Anding, WANG Yongjun, Cerebroprotection Academic Roundtable Academic Committee of Chinese Stroke Association . Scientific Statements on Brain Cytoprotection in Ischemic Stroke—A Scientific Statement from the Chinese Stroke Association [J]. Chinese Journal of Stroke, 2024, 19(8): 938-955.
[13]	LI Guangshuo, ZHAO Xingquan. Interpretation of the Chinese Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke 2023 [J]. Chinese Journal of Stroke, 2024, 19(8): 956-961.
[14]	BAI Leipeng, LUO Jie, ZHOU Sijie, HUANG Jianhui, LIANG Mingqin, ZHAO Qingshun. Interventional Thrombectomy in Patients with Acute Ischemic Stroke after Wedge Resection of Pulmonary Lobes: Two Case Reports and Literature Review [J]. Chinese Journal of Stroke, 2024, 19(8): 962-966.
[15]	ZHAO Yan, YAO Jingxin, PENG Yuming. A Report of Simultaneous Complications of Ischemic Stroke and Intracerebral Hemorrhage in Geriatric Patients Undergoing Craniotomy for Tumor Resections during the Perioperative Period [J]. Chinese Journal of Stroke, 2024, 19(7): 797-802.